When it comes to liquid biopsy, not all tests are equal. In fact, many suffer from challenges, such as low sensitivity, expensive equipment requirements, or the need for error-prone enhancement steps like pre-amplification. Can these obstacles be overcome? Certainly – and a new polymerase chain reaction technique known as single-color digital PCR can help. The assay requires very little blood, carries a price tag much lower than sophisticated sequencing methods, and bypasses the pre-amplification step and its concomitant risk of error. It’s possible that this technique, and others like it, may offer a new avenue for lower-cost, higher-accuracy liquid biopsy.
Oncology
Liquid biopsy
Technology and innovation
Profession
Precision medicine
Screening and monitoring
Clinical care
Oncology
Genetics and epigenetics
Omics
Molecular Pathology
The Chain Reaction
A new method, single-color digital PCR, can lower the cost and complexity of liquid biopsy
10/20/2017
1 min read
